Results of an early access treatment protocol of daratumumab monotherapy in spanish patients with relapsed or refractory multiple myeloma
Palabras clave :
Daratumumab
CD38-targeted
Antibody approved
Multiple myeloma
Fecha de publicación :
2020
Editorial :
Wolters Kluwer Health
Nota:
This is an open access article distributed
under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work
is properly cited.
Cita:
Alegre, A. (A.); Rubia, J. (Javier) de la; Sureda-Balari, A. (Anna); et al. "Results of an early access treatment protocol of daratumumab monotherapy in spanish patients with relapsed or refractory multiple myeloma". Hemasphere. 4 (3), 2020, e380
Aparece en las colecciones:
Estadísticas e impacto
0 citas en
Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.